METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 208.00
-14.00 (-6.31%)
Apr 27, 2026, 7:45 AM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 35.73 billion as of April 30, 2026. Its market cap has decreased by -28.44% in one year.
Market Cap
35.73B
Enterprise Value
94.79B
Revenue
32.82B
Ranking
n/a
PE Ratio
69.33
Stock Price
208.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 35.73B, a decrease of -10.27%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 35.73B | -31.80% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.85T |
| Celltrion | 42.76T |
| ALTEOGEN | 20.28T |
| Samsung Epis Holdings | 14.08T |
| Tdspharm | 51.93B |
| IVIM Technology | 51.48B |
| EOFLOW | 51.11B |
| Aprogen Biologics | 49.59B |